Kanada - angleščina - Health Canada

aspen pharmacare canada inc. - danaparoid sodium - solution - 750unit - danaparoid sodium 750unit - heparins

Združene države Amerike - angleščina - NLM (National Library of Medicine)

atlantic biologicals corps - pancrelipase lipase (unii: 8myc33932o) (pancrelipase lipase - unii:8myc33932o), pancrelipase protease (unii: 3560d81v50) (pancrelipase protease - unii:3560d81v50), pancrelipase amylase (unii: yoj58o116e) (pancrelipase amylase - unii:yoj58o116e) - creon (pancrelipase) is indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions. ® none. teratogenic effects pregnancy category c: animal reproduction studies have not been conducted with pancrelipase. it is also not known whether pancrelipase can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. creon should be given to a pregnant woman only if clearly needed. the risk and benefit of pancrelipase should be considered in the context of the need to provide adequate nutritional support to a pregnant woman with exocrine pancreatic insufficiency. adequate caloric intake during pregnancy is important for normal maternal weight gain and fetal growth. reduced maternal weight gain and malnutrition can be associated with adverse pregnancy outcomes. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, cauti

Združene države Amerike - angleščina - NLM (National Library of Medicine)

atlantic biologicals corps - pancrelipase lipase (unii: 8myc33932o) (pancrelipase lipase - unii:8myc33932o), pancrelipase protease (unii: 3560d81v50) (pancrelipase protease - unii:3560d81v50), pancrelipase amylase (unii: yoj58o116e) (pancrelipase amylase - unii:yoj58o116e) - creon (pancrelipase) is indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions. ® none. teratogenic effects pregnancy category c: animal reproduction studies have not been conducted with pancrelipase. it is also not known whether pancrelipase can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. creon should be given to a pregnant woman only if clearly needed. the risk and benefit of pancrelipase should be considered in the context of the need to provide adequate nutritional support to a pregnant woman with exocrine pancreatic insufficiency. adequate caloric intake during pregnancy is important for normal maternal weight gain and fetal growth. reduced maternal weight gain and malnutrition can be associated with adverse pregnancy outcomes. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, cauti

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - indapamide hemihydrate 2.5mg - tablet - 2.5 mg - active: indapamide hemihydrate 2.5mg excipient: hypromellose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry pink oy-6925 sodium laurilsulfate

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - fenofibrate micronised - oral capsule - 267mg

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - fenofibrate micronised - oral capsule - 267mg

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - fenofibrate micronised - oral capsule - 267mg

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - fenofibrate micronised - oral capsule - 267mg

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

stephar (u.k.) ltd - fenofibrate micronised - oral capsule - 267mg

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - fenofibrate micronised - oral capsule - 267mg